Cargando…
Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study
[Figure: see text]
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574875/ https://www.ncbi.nlm.nih.gov/pubmed/36304817 http://dx.doi.org/10.1017/jns.2022.72 |
_version_ | 1784811198501355520 |
---|---|
author | Krishnakumar, Illathu Madhavamenon Jaja-Chimedza, Asha Joseph, Ashil Balakrishnan, Abhilash Maliakel, Balu Swick, Andrew |
author_facet | Krishnakumar, Illathu Madhavamenon Jaja-Chimedza, Asha Joseph, Ashil Balakrishnan, Abhilash Maliakel, Balu Swick, Andrew |
author_sort | Krishnakumar, Illathu Madhavamenon |
collection | PubMed |
description | [Figure: see text] |
format | Online Article Text |
id | pubmed-9574875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95748752022-10-26 Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study Krishnakumar, Illathu Madhavamenon Jaja-Chimedza, Asha Joseph, Ashil Balakrishnan, Abhilash Maliakel, Balu Swick, Andrew J Nutr Sci Research Article [Figure: see text] Cambridge University Press 2022-09-09 /pmc/articles/PMC9574875/ /pubmed/36304817 http://dx.doi.org/10.1017/jns.2022.72 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. |
spellingShingle | Research Article Krishnakumar, Illathu Madhavamenon Jaja-Chimedza, Asha Joseph, Ashil Balakrishnan, Abhilash Maliakel, Balu Swick, Andrew Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study |
title | Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study |
title_full | Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study |
title_fullStr | Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study |
title_full_unstemmed | Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study |
title_short | Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study |
title_sort | enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574875/ https://www.ncbi.nlm.nih.gov/pubmed/36304817 http://dx.doi.org/10.1017/jns.2022.72 |
work_keys_str_mv | AT krishnakumarillathumadhavamenon enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy AT jajachimedzaasha enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy AT josephashil enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy AT balakrishnanabhilash enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy AT maliakelbalu enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy AT swickandrew enhancedbioavailabilityandpharmacokineticsofanovelhybridhydrogelformulationoffisetinorallyadministeredinhealthyindividualsarandomiseddoubleblindedcomparativecrossoverstudy |